Assessing the neuroprotective efficacy of low dose lithium in individuals at ultra high risk of developing psychosis
Version 2 2024-06-05, 11:34Version 2 2024-06-05, 11:34
Version 1 2021-05-13, 15:08Version 1 2021-05-13, 15:08
conference contribution
posted on 2024-06-05, 11:34authored byML Dell'Olio, GE Berger, LJ Phillips, J Regan, A Thampi, S Wood, LD Tennakoon, DC Kelly, Alison YungAlison Yung, PD McGorry
Assessing the neuroprotective efficacy of low dose lithium in individuals at ultra high risk of developing psychosis